DK147851C - Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr - Google Patents

Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr

Info

Publication number
DK147851C
DK147851C DK225073A DK225073A DK147851C DK 147851 C DK147851 C DK 147851C DK 225073 A DK225073 A DK 225073A DK 225073 A DK225073 A DK 225073A DK 147851 C DK147851 C DK 147851C
Authority
DK
Denmark
Prior art keywords
nonapeptidamide
hypophyphenic
diagnostication
gonadotropine
deficiency
Prior art date
Application number
DK225073A
Other languages
Danish (da)
English (en)
Other versions
DK147851B (da
Inventor
Mashiko Fujino
Shigeru Kobayashi
Mikihiko Obayashi
Susumu Shinagawa
Tsunehiko Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4268672A external-priority patent/JPS5324423B2/ja
Priority claimed from JP11845272A external-priority patent/JPS5324424B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to DK441083A priority Critical patent/DK149755C/da
Publication of DK147851B publication Critical patent/DK147851B/da
Application granted granted Critical
Publication of DK147851C publication Critical patent/DK147851C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK225073A 1972-04-29 1973-04-25 Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr DK147851C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK441083A DK149755C (da) 1972-04-29 1983-09-27 Analogifremgangsmaade til fremstilling af lhrh-analoge nonapeptidamidderivater eller fysiologisk acceptable salte eller metalkomplekser deraf

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4268672 1972-04-29
JP4268672A JPS5324423B2 (OSRAM) 1972-04-29 1972-04-29
JP11845272 1972-11-24
JP11845272A JPS5324424B2 (OSRAM) 1972-11-24 1972-11-24

Publications (2)

Publication Number Publication Date
DK147851B DK147851B (da) 1984-12-24
DK147851C true DK147851C (da) 1986-03-10

Family

ID=26382407

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225073A DK147851C (da) 1972-04-29 1973-04-25 Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr

Country Status (17)

Country Link
US (1) US3853837A (OSRAM)
AT (1) AT333988B (OSRAM)
AU (1) AU453931B2 (OSRAM)
CA (1) CA1005815A (OSRAM)
CH (1) CH580065A5 (OSRAM)
CS (1) CS188162B2 (OSRAM)
DE (2) DE2366379C2 (OSRAM)
DK (1) DK147851C (OSRAM)
ES (1) ES414197A1 (OSRAM)
FI (1) FI56676C (OSRAM)
FR (1) FR2183021B1 (OSRAM)
GB (1) GB1403642A (OSRAM)
HU (1) HU168696B (OSRAM)
NL (2) NL176856C (OSRAM)
NO (1) NO139560C (OSRAM)
PL (1) PL95790B1 (OSRAM)
SE (1) SE397520B (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931138A (en) * 1973-03-13 1976-01-06 Abbott Laboratories N-carbobenzoxy-pyroglutamyl-histidine
AT347054B (de) * 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US4338305A (en) * 1975-03-24 1982-07-06 American Home Products Corporation Use of LRH and LRH agonists
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NO302481B1 (no) 1990-10-16 1998-03-09 Takeda Chemical Industries Ltd Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
DK0582459T3 (da) 1992-08-07 1998-04-27 Takeda Chemical Industries Ltd Fremstilling af mikrokapsler af vandopløselige lægemidler
DE69508985T2 (de) * 1994-02-21 1999-08-19 Takeda Chemical Industries Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CN1095681C (zh) * 1996-06-20 2002-12-11 久光制药株式会社 一种用于离子电渗疗法的装置结构
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
JP4414517B2 (ja) 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ES2553136T3 (es) 2002-12-13 2015-12-04 Durect Corporation Sistema de administración oral de fármacos que comprende materiales vehículos líquidos de alta viscosidad
ATE537844T1 (de) 2004-09-17 2012-01-15 Durect Corp Dauerhafte lokalanästhetische zusammensetzung mit saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
EP2219622A1 (en) 2007-12-06 2010-08-25 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP2016515523A (ja) 2013-03-15 2016-05-30 デュレクト コーポレーション 溶解変動性を低減させるためのレオロジー改質剤を有する組成物
CN120617214A (zh) 2016-07-06 2025-09-12 度瑞公司 具有药物组成物、屏障层及药物层的口服剂型
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法
JP2024503402A (ja) 2021-01-12 2024-01-25 デュレクト コーポレーション 徐放性薬物送達システム及び関連の方法

Also Published As

Publication number Publication date
FI56676C (fi) 1980-03-10
HU168696B (OSRAM) 1976-06-28
NL7305995A (OSRAM) 1973-10-31
NO139560C (no) 1979-04-04
US3853837A (en) 1974-12-10
CH580065A5 (OSRAM) 1976-09-30
AT333988B (de) 1976-12-27
AU5467673A (en) 1974-10-17
NO139560B (no) 1978-12-27
NL930004I1 (nl) 1993-04-01
PL95790B1 (pl) 1977-11-30
SE397520B (sv) 1977-11-07
FR2183021A1 (OSRAM) 1973-12-14
DE2321174A1 (de) 1973-11-08
DE2366379C2 (de) 1985-01-17
DK147851B (da) 1984-12-24
ES414197A1 (es) 1976-05-01
FR2183021B1 (OSRAM) 1976-04-09
FI56676B (fi) 1979-11-30
CS188162B2 (en) 1979-02-28
CA1005815A (en) 1977-02-22
AU453931B2 (en) 1974-10-17
GB1403642A (en) 1975-08-28
NL176856C (nl) 1985-06-17
DE2321174C2 (de) 1982-04-15
ATA377173A (de) 1976-04-15

Similar Documents

Publication Publication Date Title
DK147851C (da) Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr
DK20979A (da) 4-amino-5-alkylsulfonyl-0-anisamid-derivater samt fremgangsmaade til fremstilling deraf
NL930029I1 (nl) Enzyme derivatives and their preparation
SE418088B (sv) Med glyoxal behandlad akrylpolymer i finfordelad form samt motsvarande framstellningsforfarande
LT2274B (lt) Benzimidazolo dariniu arba ju drusku gavimo budas
DK222382A (da) Benzezepinderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
DK301477A (da) Fremgangsmaade til stereoselektiv fremstilling af hexahydrodibenzopyranoner samt mellemprodukt til brug ved fremgangsmaaden
MX150412A (es) Mejoras en taco expansible
DK291180A (da) Indolizinderivater samt fremgangsmaade til fremstilling deraf
SE7607107L (sv) Forfarande och anleggning for reglering av fetthalten i mjolk
NL7900572A (nl) Pigmentmengsels en werkwijze voor hun bereiding.
ES237240Y (es) Envase perfeccionado para la conservacion y distribucion de liquidos.
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
AR221831A1 (es) Composicion conservadora de madera y de productos lenosos
CH532031A (de) Verfahren zur Herstellung von in 2-Stellung substituierten 5-Nitro-furan-, 5-Nitro-thiophen- und 5-Nitro-pyrrolderivaten
NL7900573A (nl) Pigmentmengsels en werkwijze voor hun bereiding.
CH484913A (de) Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2)
DK294579A (da) Antiprotozoelle oxadiazolderivater fremgangsmaade til deres fremstilling samt deres anvendelse
NL7514765A (nl) Tyrosine derivaten en werkwijze voor hun bereiding en toepassing.
IT971959B (it) Formulazione atta all impiego in isocianurati rigidi e relativi isocianurati rigidi
DK54179A (da) N-azolylalkyl-anillin samt fremgangsmaader til deres fremstilling
DK294479A (da) Antiprotozoelle oxadiazolderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK345677A (da) Fremgangsmade til fremstilling af cyanoprostaglandiner samt mellemprodukt til brug ved fremgangsmaden
IL32216A0 (en) Derivatives of the 2-(lower alkyl)-3-(lower alkyl)-4-aryl-cyclohexenylcarbinols and their preparation

Legal Events

Date Code Title Description
PUP Patent expired